MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Clinical toolkits to improve conversations about Parkinson’s dementia

    I. Dobreva, J. Thomas, M. Roche, C. Dore, S. Rose, S. Baldwin-Jones, R. O'Connell, A. Marr, C. Hugill, R. Weil (London, United Kingdom)

    Objective: To co-produce, with people living with Parkinson’s and professionals, a pair of toolkits to improve conversations about Parkinson’s dementia in the clinic: one for…
  • 2023 International Congress

    Agreement between Parkinson disease Home Diary and observer assessments before and after structured patient training

    C. Janz, J. Timpka, M. Löhle, A. Bremer, F. Gandor, G. Ebersbach, A. Storch, P. Odin (Lund, Sweden)

    Objective: The study aim was to investigate the effect of structured training concerning motor fluctuations on the agreement between observer and HD ratings and daily…
  • 2023 International Congress

    Angiotensin-converting enzyme inhibitors prevent pneumonia in patients with Parkinson’s disease

    A. Kim, JY. Joon Yeon (Cheongju-si, Republic of Korea)

    Objective: This study aimed to evaluate the effects of angiotensin-converting enzyme inhibitors (ACEi) on the prevalence of pneumonia in patients with Parkinson’s disease (PD). Background:…
  • 2023 International Congress

    Genetics of Neurogenic Orthostatic Hypotension in Parkinson’s Disease

    G. Chevalier, L. Udovin, M. Otero-Losada, S. Bordet, F. Capani, S. Luo, C. Goetz, S. Perez-Lloret (Buenos Aires, Argentina)

    Objective: We examined the association between NOH and PD-related Single Nucleotide Polymorphism (SNPs) and mapped their effects on gene expression and metabolic and signaling pathways.…
  • 2023 International Congress

    Frequency of Parkinson’s Disease in All Case Hospitalization Among Native Hawaiian/Pacific Islanders, Asian American Subgroups and Whites

    M. Bruno, M. Matsunaga, E. Krening, J. Chen, G. Ross (Honolulu, USA)

    Objective: To determine if the proportion of hospitalized patients with Parkinson’s Disease (PD) in Hawaii differs among Native Hawaiians/Pacific Islanders (NHPI), American Asians (AA), and…
  • 2023 International Congress

    Prevalence, clinical characteristics, and quality of life of orthostatic tremor and orthostatic myoclonus in Thai patients with Parkinson’s disease: Prospective cross-sectional study

    P. Kiatsermsakul, Y. Pitakpatapee, W. Saengphatarachai, K. Boonyapisit, P. Srivanitchapoom (Bangkok, Thailand)

    Objective: The primary aim was to investigate the prevalence of OT and OM in PD patients treated at Siriraj hospital. The secondary aim was to…
  • 2023 International Congress

    Long-term outcomes after subthalamic nucleus deep brain stimulation (STN-DBS) in patients with Parkinson’s Disease (PD) in Singapore

    YZ. Cai, W. Li, Y. Zheng, A. Zhan, HL. Ng, Z. Xu, KY. Tay, WL. Au, L. Tan, WH. Ng, KR. Wan, S. Neo (Singapore, Singapore)

    Objective: To evaluate the long-term outcomes of subthalamic nucleus deep brain stimulation (STN-DBS) in patients with Parkinson’s Disease (PD) up to 10 years after surgery.…
  • 2023 International Congress

    Review of NPO status on admitted PD patient outcomes

    R. Martin (Springfield, USA)

    Objective: To characterize the incidence and severity of outcomes for PD patients admitted to the hospital who miss doses of their medication. Background: PD is…
  • 2023 International Congress

    Genetic and psychiatric risk factors for impulse control disorders in de novo Parkinson’s disease

    M. Ruitenberg, E. Whooley, H. Macdonald, V. Koppelmans (Leiden, Netherlands)

    Objective: To assess the interplay of polygenic dopamine risk scores and psychiatric symptoms in the development of impulse control disorders (ICDs) in de novo patients…
  • 2023 International Congress

    Association between lifestyle and environmental factors with disease severity and age at onset in multi-ethnic Malaysian Parkinson’s disease patients

    JP. Schee, HC. Ting, ZL. Loo, AMF. Dy Closas, TS. Toh, JW. Hor, YW. Tay, JL. Lim, LC. Lit, AH. Tan, SY. Lim (Kuala Lumpur, Malaysia)

    Objective: We explored the association between self-reported exposure to caffeine, smoking, and environmental toxins (pesticides, chemical solvents, heavy metals, other chemicals, and fumes) with Aao…
  • « Previous Page
  • 1
  • …
  • 246
  • 247
  • 248
  • 249
  • 250
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley